Lyell Immunopharma to Participate in 41st Annual J.P. Morgan Healthcare Conference

January 3, 2023

https://www.globenewswire.com/news-release/2023/01/03/2582488/0/en/Lyell-Immunopharma-to-Participate-in-41st-Annual-J-P-Morgan-Healthcare-Conference.html

SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq:LYEL), a clinical-stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, announced today that members of its senior management team will present and participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10 at 4:30 pm Pacific Time.

Read more at globenewswire.com

Related news for (LYEL)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.